Which has better earnings and valuation, TKNO or CYRX?

CryoPort has higher revenue and earnings than Alpha Teknova. Alpha Teknova is trading at a lower price-to-earnings ratio than CryoPort, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Alpha Teknova $40.52M 9.71 -$17.26M -$0.31 N/A CryoPort $176.18M 4.70 $78.30M -$0.90 N/A

Is TKNO or CYRX more profitable?

CryoPort has a net margin of -20.05% compared to Alpha Teknova's net margin of -38.37%. CryoPort's return on equity of -7.20% beat Alpha Teknova's return on equity. Company Net Margins Return on Equity Return on Assets Alpha Teknova -38.37% -24.94% -16.53% CryoPort -20.05% -7.20% -4.30%

Does the media refer more to TKNO or CYRX?

In the previous week, CryoPort had 3 more articles in the media than Alpha Teknova. MarketBeat recorded 5 mentions for CryoPort and 2 mentions for Alpha Teknova. Alpha Teknova's average media sentiment score of 0.78 beat CryoPort's score of 0.45 indicating that Alpha Teknova is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Alpha Teknova 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive CryoPort 1 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has higher earnings and valuation, TKNO or EVO?

Alpha Teknova has higher earnings, but lower revenue than Evotec. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Alpha Teknova $40.52M 9.71 -$17.26M -$0.31 N/A Evotec $891.97M 0.75 -$117.12M N/A N/A

Is TKNO or EVO more profitable?

Evotec has a net margin of -26.20% compared to Alpha Teknova's net margin of -38.37%. Evotec's return on equity of -24.93% beat Alpha Teknova's return on equity. Company Net Margins Return on Equity Return on Assets Alpha Teknova -38.37% -24.94% -16.53% Evotec -26.20% -24.93% -11.35%

Does the media refer more to TKNO or EVO?

In the previous week, Evotec had 8 more articles in the media than Alpha Teknova. MarketBeat recorded 10 mentions for Evotec and 2 mentions for Alpha Teknova. Alpha Teknova's average media sentiment score of 0.78 beat Evotec's score of -0.12 indicating that Alpha Teknova is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Alpha Teknova 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Evotec 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 2 Very Negative mention(s) Neutral

Does the media prefer MLAB or TKNO?

In the previous week, Mesa Laboratories had 2 more articles in the media than Alpha Teknova. MarketBeat recorded 4 mentions for Mesa Laboratories and 2 mentions for Alpha Teknova. Mesa Laboratories' average media sentiment score of 1.10 beat Alpha Teknova's score of 0.78 indicating that Mesa Laboratories is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Mesa Laboratories 2 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Alpha Teknova 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer CTKB or TKNO?

In the previous week, Cytek Biosciences had 4 more articles in the media than Alpha Teknova. MarketBeat recorded 6 mentions for Cytek Biosciences and 2 mentions for Alpha Teknova. Alpha Teknova's average media sentiment score of 0.78 beat Cytek Biosciences' score of 0.76 indicating that Alpha Teknova is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cytek Biosciences 1 Very Positive mention(s) 3 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Alpha Teknova 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has preferable earnings and valuation, TKNO or OABI?

Alpha Teknova has higher revenue and earnings than OmniAb. Alpha Teknova is trading at a lower price-to-earnings ratio than OmniAb, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Alpha Teknova $40.52M 9.71 -$17.26M -$0.31 N/A OmniAb $18.67M 36.52 -$64.78M -$0.36 N/A

Is TKNO or OABI more profitable?

Alpha Teknova has a net margin of -38.37% compared to OmniAb's net margin of -115.12%. OmniAb's return on equity of -16.59% beat Alpha Teknova's return on equity. Company Net Margins Return on Equity Return on Assets Alpha Teknova -38.37% -24.94% -16.53% OmniAb -115.12% -16.59% -14.82%

Does the media favor TKNO or OABI?

In the previous week, OmniAb had 6 more articles in the media than Alpha Teknova. MarketBeat recorded 8 mentions for OmniAb and 2 mentions for Alpha Teknova. Alpha Teknova's average media sentiment score of 0.78 beat OmniAb's score of 0.40 indicating that Alpha Teknova is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Alpha Teknova 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive OmniAb 2 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Alpha Teknova (TKNO) Competitors

$7.34 -0.02 (-0.27%)

Closing price 04:00 PM Eastern

Extended Trading

$7.28 -0.06 (-0.82%)

As of 05:05 PM Eastern

Compare

TKNO vs. CYRX, EVO, MLAB, CTKB, and OABI

Should you buy Alpha Teknova stock or one of its competitors? Alpha Teknova's main competitors and comparable companies include CryoPort (CYRX), Evotec (EVO), Mesa Laboratories (MLAB), Cytek Biosciences (CTKB), and OmniAb (OABI). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "life sciences tools & services" industry.

How does Alpha Teknova compare to CryoPort?

Alpha Teknova (NASDAQ:TKNO) and CryoPort (NASDAQ:CYRX) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, risk, media sentiment, analyst recommendations, profitability, dividends, valuation and earnings.

CryoPort has higher revenue and earnings than Alpha Teknova. Alpha Teknova is trading at a lower price-to-earnings ratio than CryoPort, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alpha Teknova	$40.52M	9.71	-$17.26M	-$0.31	N/A
CryoPort	$176.18M	4.70	$78.30M	-$0.90	N/A

In the previous week, CryoPort had 3 more articles in the media than Alpha Teknova. MarketBeat recorded 5 mentions for CryoPort and 2 mentions for Alpha Teknova. Alpha Teknova's average media sentiment score of 0.78 beat CryoPort's score of 0.45 indicating that Alpha Teknova is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Alpha Teknova	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
CryoPort	1 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

13.8% of Alpha Teknova shares are held by institutional investors. Comparatively, 92.9% of CryoPort shares are held by institutional investors. 13.2% of Alpha Teknova shares are held by company insiders. Comparatively, 9.5% of CryoPort shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Alpha Teknova has a beta of 0.64, indicating that its stock price is 36% less volatile than the broader market. Comparatively, CryoPort has a beta of 1.89, indicating that its stock price is 89% more volatile than the broader market.

CryoPort has a net margin of -20.05% compared to Alpha Teknova's net margin of -38.37%. CryoPort's return on equity of -7.20% beat Alpha Teknova's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Alpha Teknova	-38.37%	-24.94%	-16.53%
CryoPort	-20.05%	-7.20%	-4.30%

Alpha Teknova currently has a consensus price target of $7.50, indicating a potential upside of 2.18%. CryoPort has a consensus price target of $18.00, indicating a potential upside of 10.16%. Given CryoPort's stronger consensus rating and higher possible upside, analysts plainly believe CryoPort is more favorable than Alpha Teknova.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Alpha Teknova	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
CryoPort	1 Sell rating(s)	1 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.67

Summary

CryoPort beats Alpha Teknova on 12 of the 16 factors compared between the two stocks.

How does Alpha Teknova compare to Evotec?

Alpha Teknova (NASDAQ:TKNO) and Evotec (NASDAQ:EVO) are both small-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, profitability, dividends, valuation, institutional ownership, media sentiment and earnings.

In the previous week, Evotec had 8 more articles in the media than Alpha Teknova. MarketBeat recorded 10 mentions for Evotec and 2 mentions for Alpha Teknova. Alpha Teknova's average media sentiment score of 0.78 beat Evotec's score of -0.12 indicating that Alpha Teknova is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Alpha Teknova	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Evotec	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	2 Very Negative mention(s)	Neutral

Alpha Teknova has higher earnings, but lower revenue than Evotec.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alpha Teknova	$40.52M	9.71	-$17.26M	-$0.31	N/A
Evotec	$891.97M	0.75	-$117.12M	N/A	N/A

Evotec has a net margin of -26.20% compared to Alpha Teknova's net margin of -38.37%. Evotec's return on equity of -24.93% beat Alpha Teknova's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Alpha Teknova	-38.37%	-24.94%	-16.53%
Evotec	-26.20%	-24.93%	-11.35%

Alpha Teknova has a beta of 0.64, suggesting that its share price is 36% less volatile than the broader market. Comparatively, Evotec has a beta of 1.96, suggesting that its share price is 96% more volatile than the broader market.

13.8% of Alpha Teknova shares are owned by institutional investors. Comparatively, 5.8% of Evotec shares are owned by institutional investors. 13.2% of Alpha Teknova shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Alpha Teknova presently has a consensus price target of $7.50, suggesting a potential upside of 2.18%. Evotec has a consensus price target of $3.00, suggesting a potential upside of 58.73%. Given Evotec's higher possible upside, analysts plainly believe Evotec is more favorable than Alpha Teknova.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Alpha Teknova	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
Evotec	1 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.20

Summary

Evotec beats Alpha Teknova on 7 of the 13 factors compared between the two stocks.

How does Alpha Teknova compare to Mesa Laboratories?

Mesa Laboratories (NASDAQ:MLAB) and Alpha Teknova (NASDAQ:TKNO) are both small-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, media sentiment, dividends, profitability, earnings, analyst recommendations, valuation and institutional ownership.

Mesa Laboratories has a net margin of 1.92% compared to Alpha Teknova's net margin of -38.37%. Mesa Laboratories' return on equity of 22.72% beat Alpha Teknova's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Mesa Laboratories	1.92%	22.72%	9.82%
Alpha Teknova	-38.37%	-24.94%	-16.53%

Mesa Laboratories currently has a consensus target price of $110.00, indicating a potential downside of 11.52%. Alpha Teknova has a consensus target price of $7.50, indicating a potential upside of 2.18%. Given Alpha Teknova's stronger consensus rating and higher probable upside, analysts clearly believe Alpha Teknova is more favorable than Mesa Laboratories.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Mesa Laboratories	0 Sell rating(s)	3 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Alpha Teknova	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25

Mesa Laboratories has higher revenue and earnings than Alpha Teknova. Alpha Teknova is trading at a lower price-to-earnings ratio than Mesa Laboratories, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Mesa Laboratories	$249.13M	2.79	$6.71M	$0.84	148.00
Alpha Teknova	$40.52M	9.71	-$17.26M	-$0.31	N/A

Mesa Laboratories has a beta of 0.92, indicating that its share price is 8% less volatile than the broader market. Comparatively, Alpha Teknova has a beta of 0.64, indicating that its share price is 36% less volatile than the broader market.

In the previous week, Mesa Laboratories had 2 more articles in the media than Alpha Teknova. MarketBeat recorded 4 mentions for Mesa Laboratories and 2 mentions for Alpha Teknova. Mesa Laboratories' average media sentiment score of 1.10 beat Alpha Teknova's score of 0.78 indicating that Mesa Laboratories is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Mesa Laboratories	2 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Alpha Teknova	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

90.6% of Mesa Laboratories shares are owned by institutional investors. Comparatively, 13.8% of Alpha Teknova shares are owned by institutional investors. 2.8% of Mesa Laboratories shares are owned by company insiders. Comparatively, 13.2% of Alpha Teknova shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

Mesa Laboratories beats Alpha Teknova on 11 of the 16 factors compared between the two stocks.

How does Alpha Teknova compare to Cytek Biosciences?

Cytek Biosciences (NASDAQ:CTKB) and Alpha Teknova (NASDAQ:TKNO) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, profitability, analyst recommendations, dividends, institutional ownership, media sentiment, valuation and risk.

Cytek Biosciences has a beta of 1.17, suggesting that its stock price is 17% more volatile than the broader market. Comparatively, Alpha Teknova has a beta of 0.64, suggesting that its stock price is 36% less volatile than the broader market.

Cytek Biosciences presently has a consensus price target of $5.56, suggesting a potential upside of 25.28%. Alpha Teknova has a consensus price target of $7.50, suggesting a potential upside of 2.18%. Given Cytek Biosciences' stronger consensus rating and higher possible upside, equities research analysts plainly believe Cytek Biosciences is more favorable than Alpha Teknova.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cytek Biosciences	1 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.33
Alpha Teknova	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25

69.5% of Cytek Biosciences shares are owned by institutional investors. Comparatively, 13.8% of Alpha Teknova shares are owned by institutional investors. 10.4% of Cytek Biosciences shares are owned by insiders. Comparatively, 13.2% of Alpha Teknova shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

In the previous week, Cytek Biosciences had 4 more articles in the media than Alpha Teknova. MarketBeat recorded 6 mentions for Cytek Biosciences and 2 mentions for Alpha Teknova. Alpha Teknova's average media sentiment score of 0.78 beat Cytek Biosciences' score of 0.76 indicating that Alpha Teknova is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cytek Biosciences	1 Very Positive mention(s)	3 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Alpha Teknova	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Alpha Teknova has lower revenue, but higher earnings than Cytek Biosciences. Alpha Teknova is trading at a lower price-to-earnings ratio than Cytek Biosciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cytek Biosciences	$206.71M	2.79	-$66.54M	-$0.62	N/A
Alpha Teknova	$40.52M	9.71	-$17.26M	-$0.31	N/A

Alpha Teknova has a net margin of -38.37% compared to Cytek Biosciences' net margin of -38.98%. Cytek Biosciences' return on equity of -12.40% beat Alpha Teknova's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cytek Biosciences	-38.98%	-12.40%	-9.17%
Alpha Teknova	-38.37%	-24.94%	-16.53%

Summary

Cytek Biosciences beats Alpha Teknova on 10 of the 16 factors compared between the two stocks.

How does Alpha Teknova compare to OmniAb?

Alpha Teknova (NASDAQ:TKNO) and OmniAb (NASDAQ:OABI) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, profitability, valuation, dividends, earnings, analyst recommendations, institutional ownership and risk.

Alpha Teknova currently has a consensus target price of $7.50, suggesting a potential upside of 2.18%. OmniAb has a consensus target price of $11.00, suggesting a potential upside of 133.55%. Given OmniAb's stronger consensus rating and higher possible upside, analysts clearly believe OmniAb is more favorable than Alpha Teknova.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Alpha Teknova	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
OmniAb	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

Alpha Teknova has higher revenue and earnings than OmniAb. Alpha Teknova is trading at a lower price-to-earnings ratio than OmniAb, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alpha Teknova	$40.52M	9.71	-$17.26M	-$0.31	N/A
OmniAb	$18.67M	36.52	-$64.78M	-$0.36	N/A

In the previous week, OmniAb had 6 more articles in the media than Alpha Teknova. MarketBeat recorded 8 mentions for OmniAb and 2 mentions for Alpha Teknova. Alpha Teknova's average media sentiment score of 0.78 beat OmniAb's score of 0.40 indicating that Alpha Teknova is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Alpha Teknova	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
OmniAb	2 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Alpha Teknova has a beta of 0.64, indicating that its stock price is 36% less volatile than the broader market. Comparatively, OmniAb has a beta of 0.45, indicating that its stock price is 55% less volatile than the broader market.

13.8% of Alpha Teknova shares are owned by institutional investors. Comparatively, 72.1% of OmniAb shares are owned by institutional investors. 13.2% of Alpha Teknova shares are owned by insiders. Comparatively, 9.8% of OmniAb shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Alpha Teknova has a net margin of -38.37% compared to OmniAb's net margin of -115.12%. OmniAb's return on equity of -16.59% beat Alpha Teknova's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Alpha Teknova	-38.37%	-24.94%	-16.53%
OmniAb	-115.12%	-16.59%	-14.82%

Summary

OmniAb beats Alpha Teknova on 8 of the 15 factors compared between the two stocks.

Get Alpha Teknova News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TKNO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

TKNO vs. The Competition

Export

Metric	Alpha Teknova	Life Sciences Tools & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$394.60M	$10.24B	$7.36B	$12.81B
Dividend Yield	N/A	1.46%	2.53%	10.78%
P/E Ratio	-23.68	49.98	211.91	20.71
Price / Sales	9.71	111.59	631.75	95.36
Price / Cash	N/A	27.04	29.03	36.89
Price / Book	5.73	5.47	11.18	6.40
Net Income	-$17.26M	$56.67B	$3.46B	$347.95M
7 Day Performance	1.66%	3.22%	1.98%	0.91%
1 Month Performance	47.69%	10.00%	7.32%	5.10%
1 Year Performance	54.53%	23.33%	24.76%	16.16%

Alpha Teknova Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
TKNO Alpha Teknova	1.7033 of 5 stars	$7.34 -0.3%	$7.50 +2.2%	+54.9%	$394.60M	$40.52M	N/A	240	Positive News
CYRX CryoPort	2.1539 of 5 stars	$16.36 +8.4%	$18.00 +10.1%	+91.0%	$828.63M	$176.18M	N/A	1,186
EVO Evotec	2.7115 of 5 stars	$1.97 +2.9%	$3.00 +52.7%	-47.0%	$699.07M	$891.97M	N/A	4,553
MLAB Mesa Laboratories	1.4928 of 5 stars	$116.98 +8.4%	$110.00 -6.0%	+71.0%	$655.09M	$249.13M	139.26	680	Positive News
CTKB Cytek Biosciences	2.687 of 5 stars	$4.77 +2.0%	$5.56 +16.7%	+15.9%	$619.36M	$201.49M	N/A	500

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:TKNO) was last updated on 8/24/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Alpha Teknova (TKNO) Competitors

TKNO vs. CYRX, EVO, MLAB, CTKB, and OABI

How does Alpha Teknova compare to CryoPort?

Summary

How does Alpha Teknova compare to Evotec?

Summary

How does Alpha Teknova compare to Mesa Laboratories?

Summary

How does Alpha Teknova compare to Cytek Biosciences?

Summary

How does Alpha Teknova compare to OmniAb?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TKNO vs. The Competition

Alpha Teknova Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Alpha Teknova (TKNO) Competitors

TKNO vs. CYRX, EVO, MLAB, CTKB, and OABI

How does Alpha Teknova compare to CryoPort?

Which has better earnings and valuation, TKNO or CYRX?

Does the media refer more to TKNO or CYRX?

Do institutionals & insiders have more ownership in TKNO or CYRX?

Which has more volatility and risk, TKNO or CYRX?

Is TKNO or CYRX more profitable?

Do analysts rate TKNO or CYRX?

Summary

How does Alpha Teknova compare to Evotec?

Does the media refer more to TKNO or EVO?

Which has higher earnings and valuation, TKNO or EVO?

Is TKNO or EVO more profitable?

Which has more volatility & risk, TKNO or EVO?

Do insiders and institutionals hold more shares of TKNO or EVO?

Do analysts rate TKNO or EVO?

Summary

How does Alpha Teknova compare to Mesa Laboratories?

Is MLAB or TKNO more profitable?

Do analysts prefer MLAB or TKNO?

Which has better earnings & valuation, MLAB or TKNO?

Which has more volatility & risk, MLAB or TKNO?

Does the media prefer MLAB or TKNO?

Do insiders & institutionals have more ownership in MLAB or TKNO?

Summary

How does Alpha Teknova compare to Cytek Biosciences?

Which has more volatility and risk, CTKB or TKNO?

Do analysts recommend CTKB or TKNO?

Do institutionals and insiders hold more shares of CTKB or TKNO?

Does the media prefer CTKB or TKNO?

Which has better earnings & valuation, CTKB or TKNO?

Is CTKB or TKNO more profitable?

Summary

How does Alpha Teknova compare to OmniAb?

Do analysts prefer TKNO or OABI?

Which has preferable earnings and valuation, TKNO or OABI?

Does the media favor TKNO or OABI?

Which has more volatility and risk, TKNO or OABI?

Do institutionals & insiders have more ownership in TKNO or OABI?

Is TKNO or OABI more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TKNO vs. The Competition

Alpha Teknova Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools